Skip to content

iPad Application-based Intervention for Post-stroke Depression

An iPad Application-based Intervention for Improving Post-stroke Depression Symptoms: A Pilot Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03864484
Enrollment
32
Registered
2019-03-06
Start date
2019-05-07
Completion date
2022-03-30
Last updated
2020-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke Depression

Brief summary

We plan to conduct a randomized controlled trial to examine whether usual rehabilitation plus an iPad application-based intervention improves post-stroke depression symptoms compared to usual rehabilitation alone. The purpose of this pilot randomized controlled trial is to investigate the feasibility of the final randomized controlled trial.

Interventions

DEVICEiPad Application + Usual Rehabilitation

The experimental group receives usual rehabilitation. In addition, the experimental group will watch movies using the iPad application for 3 minutes, once daily for 5 weeks.

The control group receives usual rehabilitation.

Sponsors

Kibi International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 40 years and older * Males and females * Center for Epidemiologic Studies Depression Scale score ≥16 * Mini Mental State Examination score ≥ 24 * First stroke * Native language is Japanese * Written informed consent prior to participation

Exclusion criteria

* Major depressive disorder before onset of stroke * Bilateral hemiplegia * Vision or hearing deficits that negatively impact everyday life * Severe aphasia * Severe unilateral spatial neglect * Diagnosis of neurodegenerative disease such as Parkinson's disease or multiple system atrophy * Current life-threatening severe organ failure, musculoskeletal disorders, or cancer

Design outcomes

Primary

MeasureTime frame
Depression severity as measured by the Center for Epidemiologic Studies Depression Scale (CES-D) score.Change from Baseline CES-D at 5 weeks

Secondary

MeasureTime frameDescription
Health-related quality of life as measured by the 36-item short-form Medical Outcome Study Questionnaire (SF-36).Change from Baseline SF-36 at 5 weeks
Activities of daily living as measured by Functional Independence Measure (FIM).Change from Baseline FIM at 5 weeks
Dynamic standing balance as measured by Functional Reach Test (FRT).Change from Baseline FRT at 5 weeks
Safety is defined as the proportion of patients who experience an intervention-related adverse event or any adverse event during the study.The period from the start of the intervention to 5 weeksAdverse events, whether or not considered causally related to the study intervention, include death and life-threatening illness or injury requiring prolonged hospitalization or resulting in persistent disability.

Countries

Japan

Contacts

Primary ContactHiroyuki Uchida
hiroyukiuchida02@gmail.com+81-86-427-1111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026